| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/26/2009 | EP1496929A4 Use of c5a receptor antagonist in the treatment of fibrosis |
| 08/26/2009 | EP1485087B1 (+)-2- [1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione for use in treating psoriasis by oral administration |
| 08/26/2009 | EP1218375B1 Pharmaceutically active sulfonyl amino acid derivatives |
| 08/26/2009 | CN101516893A Novel 5, 7-disubstituted [1, 3 ] thiazolo [4, 5-d] pyrimidin-2 (3h)-one derevatives and their use in therapy |
| 08/26/2009 | CN101516435A Regulation of transforming growth factor-beta (TGF-beta) gene expression in living cells via the application of specific and selective electric and electromagnetic fields |
| 08/26/2009 | CN101513524A Alpha-interferon dry powder inhalant for pigs and method for producing same |
| 08/26/2009 | CN101513511A Bezoar effervescent tablet for clearing away infantile lung heat, and preparation method thereof |
| 08/26/2009 | CN101513496A Medicine for treating epistaxis |
| 08/26/2009 | CN101513494A Medicine for treating rhinopolypus |
| 08/26/2009 | CN101513256A Glehnia littoralis can for expelling phlegm and arresting coughing and a preparation method thereof |
| 08/26/2009 | CN100531796C FGFR agonists |
| 08/26/2009 | CN100531774C A Chinese medicinal composition for treating cough and preparation method thereof |
| 08/26/2009 | CN100531765C Pinellia tuber extract and its preparation process, medicine composition and use |
| 08/26/2009 | CN100531761C Traditional Chinese medicine spray for washing and taking-care of nasal cavity |
| 08/26/2009 | CN100531745C Application of 'Kudiezi' injection in use for preparing antiviral remedy |
| 08/26/2009 | CN100531733C Aqueous pharmaceutical solution containing oxymetazoline and/or xylometazoline |
| 08/26/2009 | CN100531714C Preparing method of concentrated Shuanghuanglian oral liquid |
| 08/26/2009 | CN100531605C Tar-reducing and toxin-decreasing cigarette and its production process |
| 08/25/2009 | USRE40882 High concentration of alpha, beta or gamma interferon in buffered solution with polyvinylpyrrolidone and/or polyethylene oxide, and antioxidant, Trilon B (disodium salt of ethylenediaminetetraacetic acid); bioavailability; topical administration to mucous membrane with prolonged contact; bioavailability |
| 08/25/2009 | US7579432 Cyclic peptides as G-protein-coupled receptor antagonists |
| 08/25/2009 | US7579354 3-[4-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro- 1H-purin-8-yl)- bicyclo[2.2.2]oct-1-yl]-propionic acid or pharmaceutically acceptable salts; highly potent and selective diuretics; treatment of cardiac and circulatory disorders, degenerative disorders of central nervous system |
| 08/25/2009 | US7579348 selective antagonists of A2B adenosine receptors; for improving insulin sensitivity; asthma |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
| 08/25/2009 | US7579342 Pteridine compounds for the treatment of psoriasis |
| 08/25/2009 | US7579186 Human monoclonal antibody against TGF-β type II receptor and medicinal use thereof |
| 08/25/2009 | CA2394794C Methods for preparing pharmaceutical formulations |
| 08/25/2009 | CA2375671C 4-phenyl-pyrimidine derivatives |
| 08/25/2009 | CA2366932C Cyclic protein tyrosine kinase inhibitors |
| 08/25/2009 | CA2269246C Substituted tricyclics |
| 08/20/2009 | WO2009100592A1 Preparation of rupatadine or it's salts |
| 08/20/2009 | WO2009100530A1 Uses of modified elr-cxc chemokine g31p |
| 08/20/2009 | WO2009033789A3 Use of a peptide as a therapeutic agent |
| 08/20/2009 | WO2009033765A3 Use of a peptide as a therapeutic agent |
| 08/20/2009 | WO2009033754A3 Use of a peptide as a therapeutic agent |
| 08/20/2009 | WO2008145365A3 Treatment of surfactants with cyclodextrins |
| 08/20/2009 | US20090209570 6-Aminomorphinane Derivatives, Method for the Production and Use Thereof |
| 08/20/2009 | US20090209555 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial |
| 08/20/2009 | US20090209540 Novel Biaryl Benzolmidazole Derivatives and Pharmaceutical Composition Comprising The Same |
| 08/20/2009 | US20090209497 Method of treating lymphangioleiomyomatosis (lam) |
| 08/20/2009 | US20090209488 Compositions for the treatment of exercise induced asthma |
| 08/20/2009 | US20090208581 Formulations limiting spread of pulmonary infections |
| 08/20/2009 | DE112007001799T5 Liposomale Antioxidantien-Zusammensetzung zur Inhalation bei Erkrankungen der Lunge und der oberen Atemwege Antioxidants liposomal composition for inhalation in diseases of the lungs and upper respiratory tract |
| 08/20/2009 | CA2747133A1 Uses of modified elr-cxc chemokine g31p |
| 08/19/2009 | EP2090312A1 (S,S) reboxetine for treating attention deficit disorder |
| 08/19/2009 | EP1999113B1 Substituted 1-amino-4-phenyl-dihydroisoquinolines, method for the production thereof, use thereof as a medicament, and medicaments containing them |
| 08/19/2009 | EP1971369B1 Combination of r,r-glycopyrrolate, rolipram and budesonide for the treatment of inflammatory diseases |
| 08/19/2009 | EP1591123B1 Uses of naringenin, naringin and salts thereof as expectorants in the treatment of cough, and compositions thereof |
| 08/19/2009 | EP1482973B1 Methods of modulating cd200 receptors |
| 08/19/2009 | EP1463498B1 pharmaceutical COMPOSITION comprising a catechin, ascorbic acid, proline and lysine FOR THE TREATMENT OF NEOPLASTIC DISEASES |
| 08/19/2009 | EP1414466B1 Combinations for the treatment of inflammatory disorders |
| 08/19/2009 | EP1339425B1 Vaccine composition containing transforming growth factor alpha |
| 08/19/2009 | EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 08/19/2009 | EP1183240B1 Beta2-adrenoceptor agonists |
| 08/19/2009 | CN101511831A Adenosine derivatives as A2A receptor agonists. |
| 08/19/2009 | CN101511794A Polymorphic crystal form of a indan-2-ylamino-hydroxyethyl-quinolinone maleate derivative as beta-adrenoceptor agonist |
| 08/19/2009 | CN101511369A Methods and compositions for inhibiting angiogenesis. |
| 08/19/2009 | CN101511350A Dioxo-alkanes and dioxo-alkenes |
| 08/19/2009 | CN101511338A Liposomal composition of antioxidants for inhalations carried out during lung and upper respiratory tract diseases |
| 08/19/2009 | CN101507814A Multi-component antigen acellular pertussis vaccine and preparation method thereof |
| 08/19/2009 | CN101507799A Miao medicine 103 deer-blood element medicine for resisting multi-drug resistant pulmonary tuberculosis and preparation method of 103 deer-blood element |
| 08/19/2009 | CN101507798A Traditional Chinese medicine capable of chronic bronchitis and pulmonary heart disease |
| 08/19/2009 | CN101507794A Traditional Chinese medicine preparation capable of treating child asthma and preparation method thereof |
| 08/19/2009 | CN101507790A Preparation method of traditional Chinese medicine for treating excessive heat and toxin type acute tonsillitis |
| 08/19/2009 | CN101507767A Traditional Chinese medicine composite for treating horse pneumonia |
| 08/19/2009 | CN101507754A Traditional Chinese medicine preparation for treating coryza and preparation method thereof |
| 08/19/2009 | CN101507748A External medicine liquor for treating common cold and preparation method thereof |
| 08/19/2009 | CN101507746A Preparation method of Cordyceps kyushuensis cough-relieving oral liquid |
| 08/19/2009 | CN101507745A Buccal tablet capable of relieving itching, cough and asthma and manufacture method thereof |
| 08/19/2009 | CN101507723A Combination medicine capable of treating pneumonia and upper respiratory tract infection and preparation method thereof |
| 08/19/2009 | CN100529753C Quality controlling method for pulse restoring injection |
| 08/19/2009 | CN100529054C Modulating production of pneumococcal capsular polysaccharide |
| 08/19/2009 | CN100528899C Fusion protein and nucleic acid containing peptide carrier and epidermal growth factor and its uses |
| 08/19/2009 | CN100528874C Pyrrolo [2,3d] pyrimidine compositions and their use |
| 08/19/2009 | CN100528835C Crystalline form of beta2 adrenergic receptor agonist |
| 08/19/2009 | CN100528834C Pharmaceutical compounds |
| 08/19/2009 | CN100528205C Tupistra Chinensis Bak extract medicinal composition, and its preparation method and use same |
| 08/19/2009 | CN100528202C External application medicine on acupuncture point and its preparing method |
| 08/19/2009 | CN100528196C Chinese medicine for treating acute pharyngitis |
| 08/19/2009 | CN100528195C Preparation of dyers woad root injection |
| 08/19/2009 | CN100528193C A method for preparing houttuynia honeysuckle flower injection and product obtained thereby |
| 08/19/2009 | CN100528170C Mangiferin preparation and production thereof |
| 08/19/2009 | CN100528169C Antiinflammatory agent, agent for preventing/ameliorating allergic diseases and functional food |
| 08/19/2009 | CN100528165C Stable medicine composition of setastine or its salt |
| 08/19/2009 | CN100528159C Nicotinic receptor agonists for treatment of inflammatory diseases |
| 08/18/2009 | US7576241 e.g. 2-hydroxy-5-methoxy-N-{2-[4-[(2-thienyl(imino)methyl)amino]phenyl]ethyl)}-benzamide; nitric oxide NO-synthase enzymes inhibitor; selective or non selective traps for reactive oxygen species; antiproliferative, antiinflammatory agent |
| 08/18/2009 | US7576234 Synthesis of 2-alkyl amino acids |
| 08/18/2009 | US7576117 Cyclic amine CCR3 antagonist |
| 08/18/2009 | US7576104 4-(Aminomethyl)-2-(2,6-dioxo(3-piperidyl))isoindoline-1,3-dione hydrochloride; cytokines level reduced; tumor necrosis factor inhibitors; nontoxic; anticarcinogenic agents; antitumor agents (solid/blood-borne); cardiovascular disorders; osteoporosis; antiinflammatory agents; autoimmune diseases |
| 08/18/2009 | US7576095 2-(p-Alkoxy- or p-fluoroalkylsulonyloxyphenyl)-1-phenyl-5-cyclohexyl- or 5-(1-piperdinyl)-4,5-dihydropyrrolo[3,2-c]pyridin-4-ones; treatment of obesity, psychiatric and neurological disorders |
| 08/18/2009 | CA2412208C Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators |
| 08/18/2009 | CA2400268C Pyrrolopyrimidinone derivatives, process of preparation and use |
| 08/18/2009 | CA2392030C Urea compounds having muscarinic receptor antagonist activity |
| 08/18/2009 | CA2392028C Carbamate derivatives having muscarinic receptor antagonist activity |
| 08/18/2009 | CA2333004C Formoterol polymorphs |
| 08/18/2009 | CA2230240C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 08/13/2009 | WO2009100331A2 Compositions methods and kits for enhancing immune response to a respiratory condition |
| 08/13/2009 | WO2009100305A1 Pteridine derivatives for treating respiratory disease |
| 08/13/2009 | WO2009099901A1 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors |
| 08/13/2009 | WO2009099172A1 Pharmaceutical product |
| 08/13/2009 | WO2009099086A1 3-substituted sulfonyl piperazine derivative |